ANALYSIS GROUP

The Institute of Hematology & Blood Diseases Hospital (IHBDH) plans to develop the National Longitudinal Cohort of Hematological Diseases (NICHE), China's first prospective longitudinal national multi-disease cohort of patients with blood diseases. The cohort will initially include patients with leukemia, lymphoma, myelodysplastic syndromes, multiple myeloma, hemophilia, and various pediatric hematologic malignancies. The data from this project will be used to develop a generalizable research model to advance blood disease research in China. Analysis Group is working closely with IHBDH to facilitate the design and implementation of the research platform, and to co-organize the scientific advisory committee.

Primary location: Beijing China